These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20814765)

  • 21. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 22. Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group.
    Operskalski EA; Mosley JW; Busch MP; Stram DO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):243-4. PubMed ID: 9257660
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.
    Lyles CM; Graham NM; Astemborski J; Vlahov D; Margolick JB; Saah AJ; Farzadegan H
    Eur J Epidemiol; 1999 Feb; 15(2):99-108. PubMed ID: 10204638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
    Romeu J; Balagué M; Ruiz L; Marfil S; Puig T; Arnó A; Veny A; Tural C; Sirera G; Clotet B
    Med Clin (Barc); 1998 Jun; 110(20):761-7. PubMed ID: 9666416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France.
    Colin X; Lafuma A; Costagliola D; Lang JM; Guillon P
    Pharmacoeconomics; 2010; 28 Suppl 1():59-68. PubMed ID: 21182344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
    Montaner JS; DeMasi R; Hill AM
    AIDS; 1998 Mar; 12(5):F23-8. PubMed ID: 9543436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From HIV infection to AIDS: a dynamically induced percolation transition?
    Kamp C; Bornholdt S
    Proc Biol Sci; 2002 Oct; 269(1504):2035-40. PubMed ID: 12396503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
    Chêne G; Sterne JA; May M; Costagliola D; Ledergerber B; Phillips AN; Dabis F; Lundgren J; D'Arminio Monforte A; de Wolf F; Hogg R; Reiss P; Justice A; Leport C; Staszewski S; Gill J; Fatkenheuer G; Egger ME;
    Lancet; 2003 Aug; 362(9385):679-86. PubMed ID: 12957089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV viral load supercedes CD4 count as best marker for predicting risk of AIDS and death.
    Baker R
    BETA; 1996 Jun; ():9-11. PubMed ID: 11363652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol dependence and CD4 cell count: is there a relationship?
    Malbergier A; Amaral RA; Cardoso LD
    AIDS Care; 2015; 27(1):54-8. PubMed ID: 25179410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between cigarette smoking, virologic suppression, and CD4+ lymphocyte count in HIV-Infected Russian women.
    Brown JL; Winhusen T; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina O; Belyakov N; Rassokhin VV
    AIDS Care; 2017 Sep; 29(9):1102-1106. PubMed ID: 28497980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simian Immunodeficiency Virus Infection Increases Blood Ethanol Concentration Duration After Both Acute and Chronic Administration.
    Simon L; Siggins R; Winsauer P; Brashear M; Ferguson T; Mercante D; Song K; Vande Stouwe C; Nelson S; Bagby G; Amedee A; Molina PE
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):178-184. PubMed ID: 29037050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.
    Cheng DM; Libman H; Bridden C; Saitz R; Samet JH
    Alcohol; 2009 Feb; 43(1):65-71. PubMed ID: 19185212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD
    Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption.
    Kumar R; Perez-Casanova AE; Tirado G; Noel RJ; Torres C; Rodriguez I; Martinez M; Staprans S; Kraiselburd E; Yamamura Y; Higley JD; Kumar A
    J Acquir Immune Defic Syndr; 2005 Aug; 39(4):386-90. PubMed ID: 16010157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.